Literature DB >> 1764382

Genetic susceptibility to naevi--a twin study.

D F Easton1, G M Cox, A M Macdonald, B A Ponder.   

Abstract

The risk of malignant melanoma to an individual is strongly related to their total number of benign melanocytic naevi. To investigate the possibility that numbers of naevi may have an inherited basis, naevi were examined in 23 monozygotic and 22 dizygotic twin pairs. A strong correlation in total numbers of naevi 3 mm or more in diameter was observed between MZ twins (intraclass correlation 0.83), but there was no significant correlation between DZ twins (correlation -0.24). There was no increased concordance in presence of naevi 5 mm or more over that expected by chance, for MZ or DZ twins. The results suggest a strong inherited basis for total naevus count and hence melanoma risk, perhaps involving a number of interacting genes.

Entities:  

Mesh:

Year:  1991        PMID: 1764382      PMCID: PMC1977833          DOI: 10.1038/bjc.1991.483

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  10 in total

1.  The zygosity of twins: further evidence on the agreement between diagnosis by blood groups and written questionnaires.

Authors:  J Kasriel; L Eaves
Journal:  J Biosoc Sci       Date:  1976-07

Review 2.  Epidemiology of melanocytic nevi.

Authors:  A Green; A J Swerdlow
Journal:  Epidemiol Rev       Date:  1989       Impact factor: 6.222

3.  A method for analysing case-control studies with ordinal exposure variables.

Authors:  J Cuzick
Journal:  Biometrics       Date:  1985-09       Impact factor: 2.571

4.  Programs for Pedigree Analysis: MENDEL, FISHER, and dGENE.

Authors:  K Lange; D Weeks; M Boehnke
Journal:  Genet Epidemiol       Date:  1988       Impact factor: 2.135

5.  Volunteer bias in twin research: the rule of two-thirds.

Authors:  D T Lykken; A Tellegen; R DeRubeis
Journal:  Soc Biol       Date:  1978

Review 6.  Melanocytic naevi and melanoma: an epidemiological perspective.

Authors:  A J Swerdlow; A Green
Journal:  Br J Dermatol       Date:  1987-08       Impact factor: 9.302

7.  Twin concordance for a binary trait. I. Statistical models illustrated with data on drinking status.

Authors:  M C Hannah; J L Hopper; J D Mathews
Journal:  Acta Genet Med Gemellol (Roma)       Date:  1983

8.  Pigmentary traits, ethnic origin, benign nevi, and family history as risk factors for cutaneous malignant melanoma.

Authors:  C D Holman; B K Armstrong
Journal:  J Natl Cancer Inst       Date:  1984-02       Impact factor: 13.506

9.  Clinical and genetic studies in six Dutch kindreds with the dysplastic naevus syndrome.

Authors:  W Bergman; A Palan; L N Went
Journal:  Ann Hum Genet       Date:  1986-07       Impact factor: 1.670

10.  Cutaneous malignant melanoma and familial dysplastic nevi: evidence for autosomal dominance and pleiotropy.

Authors:  S J Bale; A Chakravarti; M H Greene
Journal:  Am J Hum Genet       Date:  1986-02       Impact factor: 11.025

  10 in total
  16 in total

1.  Melanocytic nevi, nevus genes, and melanoma risk in a large case-control study in the United Kingdom.

Authors:  Julia A Newton-Bishop; Yu-Mei Chang; Mark M Iles; John C Taylor; Bert Bakker; May Chan; Susan Leake; Birute Karpavicius; Sue Haynes; Elaine Fitzgibbon; Faye Elliott; Peter A Kanetsky; Mark Harland; Jennifer H Barrett; D Timothy Bishop
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-07-20       Impact factor: 4.254

2.  Nevus count associations with pigmentary phenotype, histopathological melanoma characteristics and survival from melanoma.

Authors:  Nicholas J Taylor; Nancy E Thomas; Hoda Anton-Culver; Bruce K Armstrong; Colin B Begg; Klaus J Busam; Anne E Cust; Terence Dwyer; Lynn From; Richard P Gallagher; Stephen B Gruber; Diane E Nishri; Irene Orlow; Stefano Rosso; Alison J Venn; Roberto Zanetti; Marianne Berwick; Peter A Kanetsky
Journal:  Int J Cancer       Date:  2016-05-30       Impact factor: 7.396

3.  Prevalence and characteristics of choroidal nevi: the multi-ethnic study of atherosclerosis.

Authors:  Max B Greenstein; Chelsea E Myers; Stacy M Meuer; Barbara E K Klein; Mary Frances Cotch; Tien Y Wong; Ronald Klein
Journal:  Ophthalmology       Date:  2011-08-04       Impact factor: 12.079

4.  Skin cancer screening behaviours among individuals with a strong family history of malignant melanoma.

Authors:  N A Kasparian; J K McLoone; B Meiser; P N Butow; J M Simpson; G J Mann
Journal:  Br J Cancer       Date:  2010-10-26       Impact factor: 7.640

Review 5.  Sun exposure and non-melanocytic skin cancer.

Authors:  A Kricker; B K Armstrong; D R English
Journal:  Cancer Causes Control       Date:  1994-07       Impact factor: 2.506

Review 6.  Clinical and histological characteristics of melanocytic nevus in external auditory canals and auricles.

Authors:  Hye Jin Lim; Yun Tae Kim; Oak-Sung Choo; Keehyun Park; Hun Yi Park; Yun-Hoon Choung
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-01-31       Impact factor: 2.503

Review 7.  Familial melanoma: a complex disorder leading to controversy on DNA testing.

Authors:  Femke A de Snoo; Wilma Bergman; Nelleke A Gruis
Journal:  Fam Cancer       Date:  2003       Impact factor: 2.375

8.  A pooled analysis of melanocytic nevus phenotype and the risk of cutaneous melanoma at different latitudes.

Authors:  Yu-mei Chang; Julia A Newton-Bishop; D Timothy Bishop; Bruce K Armstrong; Veronique Bataille; Wilma Bergman; Marianne Berwick; Paige M Bracci; J Mark Elwood; Marc S Ernstoff; Adèle C Green; Nelleke A Gruis; Elizabeth A Holly; Christian Ingvar; Peter A Kanetsky; Margaret R Karagas; Loïc Le Marchand; Rona M Mackie; Håkan Olsson; Anne Østerlind; Timothy R Rebbeck; Kristian Reich; Peter Sasieni; Victor Siskind; Anthony J Swerdlow; Linda Titus-Ernstoff; Michael S Zens; Andreas Ziegler; Jennifer H Barrett
Journal:  Int J Cancer       Date:  2009-01-15       Impact factor: 7.396

Review 9.  Melanoma risk factors and atypical moles.

Authors:  M L Williams; R W Sagebiel
Journal:  West J Med       Date:  1994-04

10.  Estimating CDKN2A carrier probability and personalizing cancer risk assessments in hereditary melanoma using MelaPRO.

Authors:  Wenyi Wang; Kristin B Niendorf; Devanshi Patel; Amanda Blackford; Fabio Marroni; Arthur J Sober; Giovanni Parmigiani; Hensin Tsao
Journal:  Cancer Res       Date:  2010-01-12       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.